| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Carcinogenesis |
Division of Molecular Epidemiology, National Center for Toxicological Research, Jefferson, Arkansas 72079 [C. B. A., P. A. T.]; Department of Social and Preventive Medicine, State University of New York at Buffalo, Buffalo, New York 14214 [J. L. F., J. E. V., S. G., R. L., T. N.]; Laboratory of Human Carcinogenesis, National Cancer Institute, Bethesda, Maryland 20892 [E. B., P. G. S.]; and Arizona Cancer Center, Tucson, Arizona 85724 [J. R. M.]
 |
ABSTRACT |
|---|
 Top ABSTRACT INTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
-tocopherol, with little increased risk for those with diets rich in these foods. Relationships were weaker among postmenopausal women, although the MnSOD AA genotype was associated with an almost 2-fold increase in risk (odds ratio, 1.8; confidence interval, 0.9–3.6). No appreciable modification of risk by diet was detected for these older women. These data support the hypothesis that MnSOD and oxidative stress play a significant role in breast cancer risk, particularly in premenopausal women. The finding that risk was greatest among women who consumed lower amounts of dietary antioxidants and was minimal among high consumers indicates that a diet rich in sources of antioxidants may minimize the deleterious effects of the MnSOD polymorphism, thereby supporting public health recommendations for the consumption of diets rich in fruits and vegetables as a preventive measure against cancer. |
INTRODUCTION |
|---|
|
TopABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
-tocopherol, and carotenoids (7
, 8)
. The mechanistic relationship of these putative risk factors, however, has not been elucidated. One hypothesis is that they affect oxidative stress and the production of ROS3
by altering the balance between prooxidant cellular activity and antioxidant defenses. These ROS are produced by normal cellular respiration and as a result of inflammation and cellular stress (9)
. When ROS are produced as a consequence of normal metabolism and in an environment in which there is sufficient antioxidant power and repair capacity, there are presumably few deleterious effects. However, when there is excessive production of ROS because of exposure to toxic agents or to pathological processes, or when there are insufficient in vivo defense mechanisms, oxidative stress may occur. This results in damage to DNA including breakage, as well as lipid peroxidation, protein modification, membrane disruption, and mitochondrial damage (10, 11, 12, 13, 14) . ROS also may be generated through the metabolism of estradiol and a variety of xenobiotics, in which superoxide anions are produced via redox cycling of quinones and semiquinones, and other intermediates (15) . Catechol estrogens and nitric oxide, which produces ROS, synergistically increase DNA damage (16) . Finally, ROS may result from peroxidation of polyunsaturated fatty acids (17) .
Together, these data indicate that oxidative stress may be related to human breast etiology. Oxidative stress has been shown to result in tumor formation in laboratory animal models, and there is other support for a role in human breast tumorigenesis (10 , 18, 19, 20, 21, 22) . Recently, it was found that BRCA1 in embryonic mouse stem cells is required for the transcription-coupled repair of oxidative damage (23) . Oxidative damage has been reported to be higher in women with breast cancer compared with controls, although studies to date remain small (24 , 25) , and these levels vary with the consumption of meats, vegetables, and fruits (26) .
Endogenous defenses against ROS include glutathione peroxidase, catalase, and SOD (9) . There are three known forms of SOD: (a) the cytosolic copper/zinc SOD; (b) the extracellular copper/zinc SOD; and (c) the mitochondrial MnSOD. MnSOD is synthesized in the cytosol and posttranscriptionally modified for transport into the mitochondrion (27 , 28) . In the mitochondrion, it catalyzes the dismutation of two superoxide radicals, producing H2O2 and oxygen. MnSOD is induced with free radical challenge (29) and cigarette smoke (30) .
Recently, two genetic variants of MnSOD were identified (28)
. A structural mutation, a T to C substitution in the mitochondrial targeting sequence, was found that changes the amino acid codon at -9 position in the signal peptide from valine (GTT) to alanine (GCT). Using a Chou Fasman analysis, Shimodo-Matsubayashi (28)
predicted that the resulting amino acid change would alter the secondary structure of the protein from an -helical structure to a ß-pleated sheet conformation. Rosenblum et al. (31)
suggest that the alteration may affect the cellular allocation of the enzyme and mitochondrial transport of MnSOD into the mitochondrion, where it would be biologically available. They further suggest that inefficient targeting of MnSOD could leave mitochondria without their full defense against superoxide radicals, which could lead to protein oxidation as well as mitochondrial DNA mutations. It is becoming increasingly clear that the mitochondrion plays a crucial role in controlling cell life and death. Apoptosis may be driven in the mitochondria by several mechanisms including disruption of electron transport, activation of caspase family proteases, and alteration of cellular reduction-oxidation potential (32)
. It has been reported that the depletion of mitochondrial DNA can affect the tumorigenic phenotype of cultured breast tumor cells (33)
. Perhaps even more importantly, overexpression of MnSOD: (a) decreases the malignant phenotypes of various types of cancer including breast cancer (34
, 35)
; (b) increases the resistance for cytotoxicity from tumor necrosis factor in breast cancer (36
, 37)
; (c) increases apoptosis (38)
; and (d) improves apoptosis after hydrogen peroxide challenge (38)
. Induction of MnSOD also increases catalase (39)
. It is also possible that mitochondrial MnSOD could impact on oxidative damage in nuclear DNA, which would be one plausible mechanism for increased risk from a genetic polymorphism in MnSOD, although the effects on the mitochondrion alone could be sufficient for its impact on carcinogenesis. Thus, there are a number of ways that affecting the cellular distribution of MnSOD might affect breast cancer risk.
To date, the frequency of this polymorphism has not been reported in Caucasians, but the frequency of the alanine and valine alleles in Japanese is 12 and 88%, respectively (28) . This is the only study to date that has investigated a disease outcome related to this MnSOD polymorphism. In a study of 83 patients with Parkinson’s disease and 140 controls, cases were more likely to have the alanine variant (28) . The investigators hypothesized that Parkinson’s disease may be related to mitochondrial stress.
Because ROS, including those generated by xenobiotics, estrogens, polyunsaturated fatty acids, ethanol, and caloric metabolism, may be involved in breast carcinogenesis, and because MnSOD is a major scavenger of ROS, we hypothesized that the MnSOD A allele could be related to breast cancer risk by having an altered capacity to reduce oxidative stress. We previously reported (40
, 41)
a 2-fold decrease in risk with higher consumption of fruits and vegetables, as well as with specific sources of the antioxidants ascorbic acid, carotenoids, and -tocopherol. Thus, we were also interested in evaluating the role of the MnSOD polymorphism in environments both rich and poor in antioxidant defenses.
|
MATERIALS AND METHODS |
|---|
|
TopABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
age 65) and the Health Care Finance Administration (> age 65). The protocol for the study was reviewed by the institutional review boards of the State University of New York at Buffalo and of all of the participating hospitals. Informed consent was received from all participants for interview and medical record review. The personal interview included a detailed, validated food frequency questionnaire, with information gathered on portion size and frequency of consumption for 72 foods 2 years before the interview. Grams of total fruit and vegetable intake were calculated and units of ascorbic acid, -tocopherol, and carotenoids computed using nutrient composition data from United States Department Agriculture data tapes and published food composition data. At the time of the interview, women were asked to provide a blood specimen; approximately 45% of premenopausal and 63% of postmenopausal women consented to phlebotomy.
Laboratory Analysis.
Genomic DNA (50 ng) was extracted from blood clots (42)
and amplified using 40 pmol of primers (5'-ACCAGCAGGCAGCTGGCGCCGG-3' and 5'-GCGTTGATGTGAGGTTCCAG-3') in reaction buffer [10 mM Tris-HCl buffer (pH 8.3), 50 mM KCl, and 1.0 mM MgCl2], and Amplitaq DNA polymerase (1.25 units; Perkin-Elmer, Norwalk, CT) with 2'-deoxynucleoside-3'-triphosphates (1.87 mM; Pharmacia, Piscataway, NJ) in a 50:l reaction volume. A mutation was introduced by a primer mismatch to create a restriction cut site for Cac8 1 in the -9Ala codon. The alanine/valine polymorphism occurs at amino acid 16, which is toward the COOH terminus of the 24-residue mitochondrial signal sequence, at nt 47, counting from the adenosine of the initial methionine codon (31)
. The PCR reaction had an initial melting temperature of 95°C (5 min) followed by 35 cycles of melting (95°C; 1 min), annealing (61°C; 1 min), and extension (72°C; 2 min). An extension period of 7 min at 72E C followed the final cycle. PCR product (10 µl) was digested with Cac8 1 (3 units; 37°C, 16 h; New England Biolabs, Beverly, MA). Digested products (87 or 93 bp) were visualized on a 4% metaphor gel (FMC Bioproducts, Rockland, ME) stained with ethidium bromide. Assay results were interpreted by two independent investigators (E. B., P. G. S.) who were blinded to case-control status; 20% of the samples were repeated for quality control to ensure that no coding errors occurred. The assay was validated by confirming polymorphic Mendelian inheritance patterns in seven human family cell lines (n = 134), encompassing three generations each (data not shown; National Institute of General Medical Sciences, Human Genetic Mutant Cell Repository, Coriell Institute, Camden, NJ). In addition, PCR product from a -9Ala and a -9Val sample underwent direct fluorescence sequencing.
Statistical Analysis.
2 analyses were used to determine the differences in distribution of the MnSOD genotype between cases and controls. ORs and 95% CIs were calculated using unconditional logistic regression to evaluate associations between MnSOD genotypes and breast cancer risk separately for premenopausal and postmenopausal women. Two models were used; one was adjusted for age and education only, and another model also included: (a) age at menarche; (b) age at first pregnancy; (c) reported family history of breast cancer; (d) body mass index; (e) total caloric intake; and (f) age at menopause for postmenopausal women. For these analyses, consumption of total fruit and vegetables and dietary antioxidants, not including supplements, was divided at the median to categorize women into high and low consumption of each factor. Separate analyses were performed to evaluate effects of the MnSOD genotype on risk within users and nonusers of supplemental antioxidants (vitamins C and E). MnSOD genotypes were collapsed into a dichotomous variable to prevent extremely small cells in stratified analyses. There was little effect on risk with one A allele; thus, women who were homozygous for the V allele were grouped with heterozygotes as the referent category. The effect of the MnSOD Ala/Ala polymorphism was then evaluated within groups of women with high and low consumption of dietary sources of specific antioxidants and vitamin supplements as well as total fruits and vegetables.
|
RESULTS |
|---|
|
TopABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
shows results for selected genotyping assays. Genotype data for MnSOD were available for 266 women with breast cancer and 295 community controls. For the most part, associations between putative risk factors for breast cancer (i.e., those for which logistic models were initially adjusted) were similar within the larger data set and the subset for which MnSOD data were available. Values for cases and controls within each group, by menopausal status are, shown in Table 1
. MnSOD allele frequencies among cases and controls are shown in Table 2
. Among controls, the A allele was present in 50% of the chromosomes evaluated, but the frequency of the A allele was higher in both pre- and postmenopausal women with breast cancer. The relationship between the MnSOD polymorphism and breast cancer risk among premenopausal and postmenopausal women is shown in Table 3
. Among premenopausal women, those with at least one A allele had little increased risk of breast cancer in comparison to women homozygous for the V alleles. Premenopausal women who were homozygous for the A allele, however, had a 4-fold increase in risk (adjusted OR, 4.3; 95% CI, 1.7–10.8) in comparison with those with V alleles.
|
|
|
|
. There was little to no increase in risk with one A allele, but those who were homozygous for the A allele had an almost 2-fold increase in risk, although the CI included unity (OR, 1.8; 95% CI, 0.9–3.6). When genotypes were dichotomized (MnSOD Val/Val and MnSOD Val/Ala combined as referent), both pre- and postmenopausal women who were homozygous for the alanine allele were at significantly increased risk of breast cancer, although, again, risk was greatest for premenopausal women.
When women were dichotomized at the median into lower and higher consumers of fruits and vegetables and sources of dietary antioxidants, we observed that the deleterious effect of the MnSOD A polymorphism was most pronounced among premenopausal women who consumed lower amounts of total fruits and vegetables (OR, 6.0; CI, 2.0–18.2; Table 4
). The effect was weaker, although still elevated, among premenopausal women who had diets rich in fruits and vegetables (OR, 3.2; CI, 1.2–8.2). Similar trends were noted for sources of ascorbic acid and -tocopherol, with the MnSOD polymorphism conferring increased risk primarily among women with diets poorer in these antioxidants. However, for the carotenoids, the MnSOD polymorphism increased risk regardless of dietary intake. Among postmenopausal women, few clear differences were observed between low and high consumers of diets rich in antioxidants, except that, among women with diets poor in sources of -tocopherol, the MnSOD polymorphism conferred a more than 2-fold risk of breast cancer with no association observed among those with higher intake of sources of -tocopherol.
|
-tocopherol (OR, 3.8; 95% CI, 1.8–8.2). For those taking these supplements, the MnSOD AA genotype did not confer increased risk. |
DISCUSSION |
|---|
|
TopABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
There is support in the literature for an association between oxidative stress and breast cancer risk. DNA damage and strand breaks are clearly linked to oxidative stress (18) , and recent work by Wang et al. (21) identified DNA-malondialdehyde adducts, markers of oxidative stress due to lipid peroxidation, in human breast tissue. Higher levels of malondialdehyde have also been noted in the urine of women with mammographic breast dysplasia (20) . Supported by indications that most breast cancer risk factors may be related to oxidative damage and that risk is reduced by the consumption of fruits and vegetables, it is plausible that SOD, the major enzyme involved in preventing oxidative stress in the mitochondrion, would also be associated with breast cancer risk. The fact that risk associated with the MnSOD polymorphism was greatest among premenopausal women who consumed low amounts of fruits and vegetables and specific sources of dietary antioxidants is consistent with their functions and that of SOD (43) . One could assume that disruption of the cellular distribution of MnSOD would have the most deleterious effects in an environment that was also low in other antioxidants.
It is unclear why effects should be strongest among premenopausal women. It may be possible that oxidative stress plays a larger role in breast carcinogenesis among these younger women, and that risk factors among postmenopausal women are less impacted by antioxidative processes. It is interesting to note that BRCA1 is required for transcription-coupled repair of oxidative DNA damage (23) . This form of breast cancer is most often seen in younger women, and the fact that the effects of the MnSOD polymorphism were greatest among premenopausal women may be driven, to some degree, by less efficient DNA repair. Although we do not have information on the frequency of BRCA1 mutations among participants in this study, we did evaluate relationships with family history of breast cancer. Among postmenopausal women, associations between breast cancer and MnSOD did not differ by family history. However, among premenopausal women, all women with a family history of breast cancer who were also homozygous for the MnSOD A alleles had breast cancer (n = 7). There were no controls with both mutations. Although numbers are small, these data indicate that inefficient response to oxidative damage, coupled with inefficient DNA repair, could act synergistically in breast cancer etiology. Examination of the MnSOD polymorphism among women with and without BRCA1 mutations would be of great interest for elucidation of these relationships.
MnSOD may play a dual role in relation to exposure to ROS. Human cancer frequently has decreased MnSOD levels. However, although it is clearly an important scavenger of ROS, the production of H2O2 by MnSOD in specific circumstances may lead to potentially carcinogenic effects, especially if some individuals have a decreased capacity to remove H2O2 by glutathione peroxidase or catalase. Alternatively, better scavenging capacity may decrease the ability to undergo normal cellular protective mechanisms such as apoptosis; therefore, oxidative stresses would have a greater likelihood of nuclear DNA mutation (9 , 44) . It is important to realize, however, that the prediction of an altered cellular distribution of the MnSOD protein is only based on a limited statistical model, and further confirmation is required. Also, whether an overproduction of H2O2 affects cellular function (e.g., increases DNA damage or adversely affects signal transduction or transcription of early cancer genes) has not yet been shown. These are questions that merit focused research.
Results from these analyses may be affected by sources of bias that are common to case-control studies, and the limitations of this case-control study population have been discussed in depth previously (40, 41, 42 , 45 , 46) . Low participation rates may produce results that are not generalizable to all women. However, there is little reason to believe that nonparticipation would be related to genotype. Of concern are the limited sample numbers in this study. Resulting estimates of risk may be unstable, as evidenced by wide confidence intervals, and due to chance alone. Nonetheless, these data are consistent with biologically plausible interactions and merit further investigation of the MnSOD polymorphism in relation to breast cancer risk.
To our knowledge, this is the first study to evaluate the prevalence of the MnSOD polymorphism in a Caucasian population or to examine the association between the polymorphism and risk of cancer. The MnSOD genetic polymorphism was only recently identified, and, clearly, there is a need for biochemical studies to evaluate the effects of the polymorphism on the activity and distribution of SOD in the mitochondrion, possible effects on the cell, and sensitivity to damage by ROS. Although genotype is unalterable, it is encouraging to note that the effects of the MnSOD polymorphism were noted primarily among women who consumed low amounts of fruits and vegetables and other sources of dietary antioxidants and that risk was reduced with increased consumption. If these findings are corroborated, they will not only further elucidate breast cancer etiology but also reinforce public health recommendations for consumption of diets rich in fruits, vegetables, and other sources of antioxidants as a measure of cancer prevention.
|
ACKNOWLEDGMENTS |
|---|
|
FOOTNOTES |
|---|
1 This work was supported in part by Grants CA11535, CA/ES62995, and CA01633 from the National Cancer Institute and the National Institute for Environmental Health Sciences and USAMRMC#CAMC 17-94-J-4108 and from the U.S. Department of Defense DAMD 17-95-1-5022. 
2 To whom requests for reprints should be addressed, at Division of Molecular Epidemiology, National Center for Toxicological Research, 3900 NCTR Road, Jefferson, AR, 72079.
3 The abbreviations used are: ROS, reactive oxygen species; SOD, superoxide dismutase; MnSOD, manganese SOD; OR, odds ratio; CI, confidence interval.
Received 9/24/98. Accepted 12/ 3/98.
|
REFERENCES |
|---|
|
TopABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
This article has been cited by other articles:
|
|
 |
|
  J. M. Chan, W. K. Oh, W. Xie, M. M. Regan, M. J. Stampfer, I. B. King, M. Abe, and P. W. Kantoff Plasma Selenium, Manganese Superoxide Dismutase, and Intermediate- or High-Risk Prostate Cancer J. Clin. Oncol., August 1, 2009; 27(22): 3577 - 3583. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Sun, I. R. Konig, and N. Homann Manganese Superoxide Dismutase (MnSOD) Polymorphism, Alcohol, Cigarette Smoking and Risk of Oesophageal Cancer Alcohol Alcohol., July 1, 2009; 44(4): 353 - 357. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. Glynn, B. J. Boersma, T. M. Howe, H. Edvardsen, S. B. Geisler, J. E. Goodman, L. A. Ridnour, P. E. Lonning, A.-L. Borresen-Dale, B. Naume, et al. A Mitochondrial Target Sequence Polymorphism in Manganese Superoxide Dismutase Predicts Inferior Survival in Breast Cancer Patients Treated with Cyclophosphamide Clin. Cancer Res., June 15, 2009; 15(12): 4165 - 4173. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Bag and N. Bag Target Sequence Polymorphism of Human Manganese Superoxide Dismutase Gene and Its Association with Cancer Risk: A Review Cancer Epidemiol. Biomarkers Prev., December 1, 2008; 17(12): 3298 - 3305. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Xu, F. Fang, S. K. Dhar, A. Bosch, W. H. St. Clair, E. J. Kasarskis, and D. K. St. Clair Mutations in the SOD2 Promoter Reveal a Molecular Basis for an Activating Protein 2-Dependent Dysregulation of Manganese Superoxide Dismutase Expression in Cancer Cells Mol. Cancer Res., December 1, 2008; 6(12): 1881 - 1893. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Mikhak, D. J. Hunter, D. Spiegelman, E. A. Platz, K. Wu, J. W. Erdman Jr, and E. Giovannucci Manganese superoxide dismutase (MnSOD) gene polymorphism, interactions with carotenoid levels and prostate cancer risk Carcinogenesis, December 1, 2008; 29(12): 2335 - 2340. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. E Fabre, A. Raynaud-Simon, J.-L. Golmard, M. Hebert, X. Dulcire, M. Succari, J. Myara, D. Durand, and V. Nivet-Antoine Gene polymorphisms of oxidative stress enzymes: prediction of elderly renutrition Am. J. Clinical Nutrition, May 1, 2008; 87(5): 1504 - 1512. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-Y. Choi, M. L. Neuhouser, M. J. Barnett, C.-C. Hong, A. R. Kristal, M. D. Thornquist, I. B. King, G. E. Goodman, and C. B. Ambrosone Iron intake, oxidative stress-related genes (MnSOD and MPO) and prostate cancer risk in CARET cohort Carcinogenesis, May 1, 2008; 29(5): 964 - 970. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Rajaraman, A. Hutchinson, N. Rothman, P. M. Black, H. A. Fine, J. S. Loeffler, R. G. Selker, W. R. Shapiro, M. S. Linet, and P. D. Inskip Oxidative response gene polymorphisms and risk of adult brain tumors Neuro-oncol, January 1, 2008; 10(5): 709 - 715. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. M. Connor, N. Hempel, K. K. Nelson, G. Dabiri, A. Gamarra, J. Belarmino, L. Van De Water, B. M. Mian, and J. A. Melendez Manganese Superoxide Dismutase Enhances the Invasive and Migratory Activity of Tumor Cells Cancer Res., November 1, 2007; 67(21): 10260 - 10267. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. W. Mak, S. P. Ho, W. C. Yu, K. L. Choo, C. M. Chu, W. W. Yew, W. K. Lam, M. Chan-Yeung, and on behalf of the Hong Kong Thoracic Society Chroni Polymorphisms and functional activity in superoxide dismutase and catalase genes in smokers with COPD Eur. Respir. J., October 1, 2007; 30(4): 684 - 690. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Kang, K.-M. Lee, S. K. Park, S. I. Berndt, U. Peters, D. Reding, N. Chatterjee, R. Welch, S. Chanock, W.-Y. Huang, et al. Functional Variant of Manganese Superoxide Dismutase (SOD2 V16A) Polymorphism Is Associated with Prostate Cancer Risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Study Cancer Epidemiol. Biomarkers Prev., August 1, 2007; 16(8): 1581 - 1586. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-Y. Choi, M. L. Neuhouser, M. Barnett, M. Hudson, A. R. Kristal, M. Thornquist, I. B. King, G. E. Goodman, and C. B. Ambrosone Polymorphisms in Oxidative Stress-Related Genes Are Not Associated with Prostate Cancer Risk in Heavy Smokers Cancer Epidemiol. Biomarkers Prev., June 1, 2007; 16(6): 1115 - 1120. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R.-K. Bai, S. M. Leal, D. Covarrubias, A. Liu, and L.-J. C. Wong Mitochondrial Genetic Background Modifies Breast Cancer Risk Cancer Res., May 15, 2007; 67(10): 4687 - 4694. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Vogel, J. Christensen, B. A Nexo, H. Wallin, S. Friis, and A. Tjonneland Peroxisome profilerator-activated receptor{gamma}2 Pro12Ala, interaction with alcohol intake and NSAID use, in relation to risk of breast cancer in a prospective study of Danes Carcinogenesis, February 1, 2007; 28(2): 427 - 434. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Mathers and J. E. Hesketh The Biological Revolution: Understanding the Impact of SNPs on Diet-Cancer Interrelationships J. Nutr., January 1, 2007; 137(1): 253S - 258S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Ahn, C. B. Ambrosone, P. A. Kanetsky, C. Tian, T. A. Lehman, S. Kropp, I. Helmbold, D. von Fournier, W. Haase, M. L. Sautter-Bihl, et al. Polymorphisms in Genes Related to Oxidative Stress (CAT, MnSOD, MPO, and eNOS) and Acute Toxicities from Radiation Therapy following Lumpectomy for Breast Cancer Clin. Cancer Res., December 1, 2006; 12(23): 7063 - 7070. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 The Breast Cancer Association Consortium Commonly studied single-nucleotide polymorphisms and breast cancer: results from the Breast Cancer Association Consortium. J Natl Cancer Inst, October 4, 2006; 98(19): 1382 - 1396. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Ravn-Haren, A. Olsen, A. Tjonneland, L. O. Dragsted, B. A. Nexo, H. Wallin, K. Overvad, O. Raaschou-Nielsen, and U. Vogel Associations between GPX1 Pro198Leu polymorphism, erythrocyte GPX activity, alcohol consumption and breast cancer risk in a prospective cohort study Carcinogenesis, April 1, 2006; 27(4): 820 - 825. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Sutton, P. Nahon, D. Pessayre, P. Rufat, A. Poire, M. Ziol, D. Vidaud, N. Barget, N. Ganne-Carrie, N. Charnaux, et al. Genetic polymorphisms in antioxidant enzymes modulate hepatic iron accumulation and hepatocellular carcinoma development in patients with alcohol-induced cirrhosis. Cancer Res., March 1, 2006; 66(5): 2844 - 2852. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Cebrian, P. D. Pharoah, S. Ahmed, P. L. Smith, C. Luccarini, R. Luben, K. Redman, H. Munday, D. F. Easton, A. M. Dunning, et al. Tagging Single-Nucleotide Polymorphisms in Antioxidant Defense Enzymes and Susceptibility to Breast Cancer Cancer Res., January 15, 2006; 66(2): 1225 - 1233. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Forlenza and G. E. Miller Increased Serum Levels of 8-Hydroxy-2'-Deoxyguanosine in Clinical Depression Psychosom Med, January 1, 2006; 68(1): 1 - 7. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Ahn, M. D. Gammon, R. M. Santella, M. M. Gaudet, J. A. Britton, S. L. Teitelbaum, M. B. Terry, S. Nowell, W. Davis, C. Garza, et al. Associations between Breast Cancer Risk and the Catalase Genotype, Fruit and Vegetable Consumption, and Supplement Use Am. J. Epidemiol., November 15, 2005; 162(10): 943 - 952. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Fenech The Genome Health Clinic and Genome Health Nutrigenomics concepts: diagnosis and nutritional treatment of genome and epigenome damage on an individual basis Mutagenesis, July 1, 2005; 20(4): 255 - 269. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Taufer, A. Peres, V. M. de Andrade, G. de Oliveira, G. Sa, M. E. P. do Canto, A. R. dos Santos, M. E. Bauer, and I. B. M. da Cruz Is the Val16Ala Manganese Superoxide Dismutase Polymorphism Associated With the Aging Process? J. Gerontol. A Biol. Sci. Med. Sci., April 1, 2005; 60(4): 432 - 438. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Li, P. W. Kantoff, E. Giovannucci, M. F. Leitzmann, J. M. Gaziano, M. J. Stampfer, and J. Ma Manganese Superoxide Dismutase Polymorphism, Prediagnostic Antioxidant Status, and Risk of Clinical Significant Prostate Cancer Cancer Res., March 15, 2005; 65(6): 2498 - 2504. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. B. Ambrosone, J. Ahn, K. K. Singh, H. Rezaishiraz, H. Furberg, C. Sweeney, B. Coles, and A. Trovato Polymorphisms in Genes Related to Oxidative Stress (MPO, MnSOD, CAT) and Survival After Treatment for Breast Cancer Cancer Res., February 1, 2005; 65(3): 1105 - 1111. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Morgenstern Oxidative Stress and Human Genetic Variation J. Nutr., November 1, 2004; 134(11): 3173S - 3174S. [Full Text] [PDF]
|
|
|
|
|
|
D. St. Clair Manganese Superoxide Dismutase: Genetic Variation and Regulation J. Nutr., November 1, 2004; 134(11): 3190S - 3191S. [Full Text] [PDF]
|
|
|
|
 |
|
 G. Fortunato, E. Marciano, F. Zarrilli, C. Mazzaccara, M. Intrieri, G. Calcagno, D. F. Vitale, P. La Manna, C. Saulino, V. Marcelli, et al. Paraoxonase and Superoxide Dismutase Gene Polymorphisms and Noise-Induced Hearing Loss Clin. Chem., November 1, 2004; 50(11): 2012 - 2018. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Ahn, M. D. Gammon, R. M. Santella, M. M. Gaudet, J. A. Britton, S. L. Teitelbaum, M. B. Terry, A. I. Neugut, P. D. Josephy, and C. B. Ambrosone Myeloperoxidase Genotype, Fruit and Vegetable Consumption, and Breast Cancer Risk Cancer Res., October 15, 2004; 64(20): 7634 - 7639. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. L. Kinnula, T. Torkkeli, P. Kristo, R. Sormunen, Y. Soini, P. Paakko, T. Ollikainen, K. Kahlos, A. Hirvonen, and S. Knuutila Ultrastructural and Chromosomal Studies on Manganese Superoxide Dismutase in Malignant Mesothelioma Am. J. Respir. Cell Mol. Biol., August 1, 2004; 31(2): 147 - 153. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Tamimi, S. E. Hankinson, D. Spiegelman, G. A. Colditz, and D. J. Hunter Manganese Superoxide Dismutase Polymorphism, Plasma Antioxidants, Cigarette Smoking, and Risk of Breast Cancer Cancer Epidemiol. Biomarkers Prev., June 1, 2004; 13(6): 989 - 996. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Hung, P. Boffetta, P. Brennan, C. Malaveille, U. Gelatti, D. Placidi, A. Carta, A. Hautefeuille, and S. Porru Genetic polymorphisms of MPO, COMT, MnSOD, NQO1, interactions with environmental exposures and bladder cancer risk Carcinogenesis, June 1, 2004; 25(6): 973 - 978. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. L'Ecuyer, Z. Allebban, R. Thomas, and R. Vander Heide Glutathione S-transferase overexpression protects against anthracycline-induced H9C2 cell death Am J Physiol Heart Circ Physiol, June 1, 2004; 286(6): H2057 - H2064. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. J. Ladas, J. S. Jacobson, D. D. Kennedy, K. Teel, A. Fleischauer, and K. M. Kelly Antioxidants and Cancer Therapy: A Systematic Review J. Clin. Oncol., February 1, 2004; 22(3): 517 - 528. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Knight, U. V. Onay, S. Wells, H. Li, E. J. Q. Shi, I. L. Andrulis, and H. Ozcelik Genetic Variants of GPX1 and SOD2 and Breast Cancer Risk at the Ontario Site of the Breast Cancer Family Registry Cancer Epidemiol. Biomarkers Prev., January 1, 2004; 13(1): 146 - 149. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-P. Fu, J.-C. Yu, T.-C. Cheng, M. A. Lou, G.-C. Hsu, C.-Y. Wu, S.-T. Chen, H.-S. Wu, P.-E. Wu, and C.-Y. Shen Breast Cancer Risk Associated with Genotypic Polymorphism of the Nonhomologous End-Joining Genes: A Multigenic Study on Cancer Susceptibility Cancer Res., May 15, 2003; 63(10): 2440 - 2446. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Goldman and P. G. Shields Food Mutagens J. Nutr., March 1, 2003; 133(3): 965S - 973. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. K. Nelson, A. C. Ranganathan, J. Mansouri, A. M. Rodriguez, K. M. Providence, J. L. Rutter, K. Pumiglia, J. A. Bennett, and J. A. Melendez Elevated Sod2 Activity Augments Matrix Metalloproteinase Expression: Evidence for the Involvement of Endogenous Hydrogen Peroxide in Regulating Metastasis Clin. Cancer Res., January 1, 2003; 9(1): 424 - 432. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Naderi-Hachtroudi, T. Peters, P. Brenneisen, C. Meewes, C. Hommel, Z. Razi-Wolf, L. A. Schneider, J. Schuller, M. Wlaschek, and K. Scharffetter-Kochanek Induction of Manganese Superoxide Dismutase in Human Dermal Fibroblasts: A UV-B-Mediated Paracrine Mechanism With the Release of Epidermal Interleukin 1{alpha}, Interleukin 1{beta}, and Tumor Necrosis Factor {alpha} Arch Dermatol, November 1, 2002; 138(11): 1473 - 1479. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Levine, E. Elkhouly, A. T. Diep, E. R. Lee, H. Frankl, and R. W. Haile The MnSOD A16V Mitochondrial Targeting Sequence Polymorphism Is Not Associated with Increased Risk of Distal Colorectal Adenomas: Data from a Sigmoidoscopy-based Case Control Study Cancer Epidemiol. Biomarkers Prev., October 1, 2002; 11(10): 1140 - 1141. [Full Text] [PDF]
|
|
|
|
 |
|
 T. D. Oberley Oxidative Damage and Cancer Am. J. Pathol., February 1, 2002; 160(2): 403 - 408. [Full Text] [PDF]
|
|
|
|
|
|
L. I. Wang, D. P. Miller, Y. Sai, G. Liu, L. Su, J. C. Wain, T. J. Lynch, and D. C. Christiani Manganese Superoxide Dismutase Alanine-to-Valine Polymorphism at Codon 16 and Lung Cancer Risk J Natl Cancer Inst, December 5, 2001; 93(23): 1818 - 1821. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Angelova, P. Dolashka-Angelova, E. Ivanova, J. Serkedjieva, L. Slokoska, S. Pashova, R. Toshkova, S. Vassilev, I. Simeonov, H.-J. Hartmann, et al. A novel glycosylated Cu/Zn-containing superoxide dismutase: production and potential therapeutic effect Microbiology, June 1, 2001; 147(6): 1641 - 1650. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Mitrunen, P. Sillanpaa, V. Kataja, M. Eskelinen, V.-M. Kosma, S. Benhamou, M. Uusitupa, and A. Hirvonen Association between manganese superoxide dismutase (MnSOD) gene polymorphism and breast cancer risk Carcinogenesis, May 1, 2001; 22(5): 827 - 829. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Miranda, L. Janssen, C. B. Bosman, W. van Duijn, M. M. Oostendorp-van de Ruit, F. J. G. M. Kubben, G. Griffioen, C. B. H. W. Lamers, J. Han, J. M. van Krieken, et al. Superoxide Dismutases in Gastric and Esophageal Cancer and the Prognostic Impact in Gastric Cancer Clin. Cancer Res., August 1, 2000; 6(8): 3183 - 3192. [Abstract] [Full Text]
|
|
|
|
 |
|
 P. A. Thompson and C. Ambrosone Chapter 7: Molecular Epidemiology of Genetic Polymorphisms in Estrogen Metabolizing Enzymes in Human Breast Cancer J Natl Cancer Inst Monographs, July 1, 2000; 2000(27): 125 - 134. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. J. Zhang, T. Yan, T. D. Oberley, and L. W. Oberley Comparison of Effects of Two Polymorphic Variants of Manganese Superoxide Dismutase on Human Breast MCF-7 Cancer Cell Phenotype Cancer Res., December 1, 1999; 59(24): 6276 - 6283. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
